Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | 
|---|---|---|---|---|
| 1 | ||||
| Ataxia | Ataxia | x | ||
| Confusional state | Confusional state | x | ||
| Feeling abnormal | Confusional state | x | ||
| Diplopia | Diplopia | x | ||
| Dizziness | Dizziness | x | ||
| Somnolence | Drowsiness | x | ||
| Dermatitis | Rash | x | ||
| Rash | Rash | x | ||
| Asthenia | Fatigue | x | ||
| Fatigue | Fatigue | x | ||
| Headache | Headache | x | ||
| Irritability | Irritability | x | ||
| Nervousness | Nervousness | x | ||
| Tension | Nervousness | x | ||
| Tremor | Tremor | x | ||
| Dry mouth | Dry mouth | x | ||
| Dysarthria | Slurred speech | x | ||
| Blood pressure systolic decreased | Blood pressure systolic decreased | x | ||
| Vision blurred | Vision blurred | x | ||
| Haematocrit decreased | Haematocrit decreased | x | ||
| Insomnia | Insomnia | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |